Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

ETA receptor antagonist [BQ-123] . sodium salt

 
ALX-155-004-P001 1 mg* 117.00 USD
 
ALX-155-004-P005 5 mg* 435.00 USD
Do you need bulk/larger quantities?
 
Highly potent and selective ETA antagonist.

Product Specification

Sequence:cyclo(D-Asp-Pro-D-Val-Leu-D-Trp . Na)
 
Formula:C31H42N6O7 . Na
 
MW:633.7
 
CAS:136553-81-6
 
Quantity:*Sold as net peptide weight.
 
Purity:≥96%
 
Solubility:Soluble in water.
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
Use/Stability:Stable for at least 3 years after receipt when stored at -20°C. Stock solutions are stable for up to 3 months when stored at -20°C.
 
ALX-155-004
Please mouse over
ALX-155-004

Product Literature References

Endothelin: progress in pharmacology and physiology: W.G. Haynes, et al.; TIPS 14, 225 (1993), (Review), Abstract;
A novel ETA antagonist (BQ-123) inhibits endothelin-1-induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells: S. Eguchi, et al.; FEBS Lett. 302, 243 (1992), Abstract;
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor: M. Ihara, et al.; Life Sci. 50, 247 (1992), Abstract;
Conformational study of cyclo[D-Trp-D-Asp-Pro-D-Val-Leu], an endothelin- A receptor-selective antagonist: R.A. Atkinson & J.T. Pelton; FEBS Lett. 296, 1 (1992), Abstract;
Cyclic pentapeptide endothelin antagonists with high ETA selectivity. Potency- and solubility-enhancing modifications: K. Ishikawa, et al.; J. Med. Chem. 35, 2139 (1992), Abstract;
Identification of a domain of ETA receptor required for ligand binding: M. Adachi, et al.; FEBS Lett. 311, 179 (1992), Abstract;

Related Literature

Product Flyers
Antiviral Signaling
Antiviral Signaling
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,